Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.38 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.38 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 known ✓ | P35367 | 1/20 | 0.38 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 5/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tartaric Acid SCHEMBL30771976 | 0.94 | TSHR (0.67) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL282045 | 0.94 | TSHR (0.67) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27981116 | 0.91 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27681738 | 0.91 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL7337182 | 0.91 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL27681736 | 0.91 | TSHR (0.62) | TSHRCYP2C9PDE4AOR51E2TP53 | |
| Cadaverine Tartrate SCHEMBL42202 | 0.91 | TSHR (0.71) | TSHRCYP2C9PDE4ATHPOOR51E2 | |
| Cadaverine Tartrate SCHEMBL27525534 | 0.88 | TSHR (0.67) | TSHRCYP2C9PDE4ATHPOOR51E2 | |
| Cadaverine Tartrate SCHEMBL321623 | 0.87 | TSHR (0.50) | TSHRCYP2C9PDE4ATHPOOR51E2 | |
| Cadaverine Tartrate SCHEMBL18987140 | 0.84 | TSHR (0.71) | TSHRCYP2C9PDE4AOR51E2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0754031-B1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | SHIRE LAB INC (US) | 2004-03-24 | — | — | EP | claimed |
| EP-0754031-A4 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE INC (US) | 2000-01-19 | — | — | EP | claimed |
| EP-0840611-A1 | ORAL ACYCLOVIR DELIVERY | PHARMAVENE, INC. (US) | 1998-05-13 | — | — | EP | claimed |
| EP-0788346-A4 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE INC (US) | 1998-05-06 | — | — | EP | claimed |
| EP-0788346-A1 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1997-08-13 | — | — | EP | claimed |
| EP-0754031-A1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1997-01-22 | — | — | EP | claimed |
| WO-1996040144-A1 | ORAL ACYCLOVIR DELIVERY | PHARMAVENE, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| WO-1996037215-A1 | ORAL INSULIN DELIVERY | PHARMAVENE, INC. (US) | 1996-11-28 | — | — | WO | claimed |
| WO-1995027479-A1 | MULTILAMELLAR DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1995-10-19 | — | — | WO | claimed |
| WO-1995025504-A1 | EMULSIFIED DRUG DELIVERY SYSTEMS | PHARMAVENE, INC. (US) | 1995-09-28 | — | — | WO | claimed |
| US-5447729-A | Hydrophilic-hydrophobic layers | PHARMAVENE, INC. (US) | 1995-09-05 | — | — | US | claimed |